Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
about
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulatorsMatrix metalloproteinases in kidney homeostasis and diseasesAdipose extracellular matrix remodelling in obesity and insulin resistanceGlibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.Mesangial pathology in glomerular disease: targets for therapeutic intervention.Reductions in laminin beta2 mRNA translation are responsible for impaired IGFBP-5-mediated mesangial cell migration in the presence of high glucose.MMP-2 mediates local degradation and remodeling of collagen by annulus fibrosus cells of the intervertebral disc.Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice.The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary.Systematic profiling of mRNA and miRNA expression in the pancreatic islets of spontaneously diabetic Goto-Kakizaki ratsA glimpse of matrix metalloproteinases in diabetic nephropathy.Anti-diabetic effects of ethanol extract of Bryonia laciniosa seeds and its saponins rich fraction in neonatally streptozotocin-induced diabetic rats.Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin.Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy.The extracellular matrix and insulin resistance.Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth.Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments.C-peptide exhibits a late induction effect on matrix metallopeptidase-9 in high glucose-stimulated rat mesangial cells.Oxidative stress and diabetic kidney disease.An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases.Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.Differential effects of Smad3 targeting in a murine model of chronic kidney diseaseRethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.Proteases in Plasma and Kidney of db/db Mice as Markers of Diabetes-Induced Nephropathy.Matrix Metalloproteinase-9 -1562C/T Gene Polymorphism Is Associated with Diabetic Nephropathy.Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells.Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration.Effect of non-surgical periodontal therapy on C-reactive protein, oxidative stress, and matrix metalloproteinase (MMP)-9 and MMP-2 levels in patients with type 2 diabetes: a randomized controlled study.
P2860
Q27000495-08C3EE00-76D1-4B4B-8D0E-756036EAF7CEQ27004621-044859C9-668F-49D0-BC38-87BAA2539060Q28069494-192AF254-737F-41DC-81B9-DFAFAE5541F2Q29347062-B7D369BB-5368-4578-82F8-3D78AA4EEE56Q30427166-88D2D80E-11D0-4752-B188-56280C9B487CQ30429535-D4730B9E-0433-4552-B7CF-8CDAED3BD3AFQ33655715-A16C8B44-356E-4174-9A97-9772AD4A1F25Q33767133-12394308-C0DE-433A-AA02-D38ECEE636F5Q33994864-6254D3C0-B92C-4ED8-94AE-9BAF38311476Q34022639-916A2490-762B-4EC0-8729-12EDE3C8B071Q34138756-1D0787FC-DC99-4585-AF8B-A3AEE0662095Q34377973-07143226-7EA1-4082-9464-AE117F28E8B8Q34540892-73FBEEB8-A59E-4B4A-9181-A9351CFABF63Q34796034-991038BD-65C6-43C6-B6CB-00BD87E7565CQ34849503-F0C56F95-961E-4D3C-8013-2C1A75AE3F93Q34975684-F3085E47-3DAB-44E6-A1A7-422088B61207Q35248154-F60411BD-BDA8-4D1D-85FA-A415A0287CBEQ35812133-2FDC5A9C-BF7E-4B8B-AFC2-8C1B8651A997Q36206158-68A12120-3783-412C-9930-0E810F81B9E1Q36773725-F1DB906E-7CD3-4611-9E81-7367ABD51BBEQ36891626-47E71547-7C75-40E3-999B-BF92CC346BD9Q37241389-11A702D8-F49F-46D1-B6A6-C4471674AE09Q37242419-BA84A313-E490-48B5-91B6-C70A5EF65504Q37477458-E87491B3-D328-40E9-8C5E-E52B127A1DD2Q37581535-3674C74D-2527-4939-828B-D3DD34773709Q37873829-E1BAAA59-F78F-48CB-A972-15D81A1075F5Q37955866-5021B156-8DEF-4598-9931-E20C58A12468Q38203501-953F6771-D72F-4624-A120-769FFC849E5BQ38222628-4F31F9D1-DD38-4A78-B8FE-5105FE4227B5Q38253072-5417FE4D-02DE-4E3A-AE40-CC8EA0ACDCDBQ38568865-6392F4BE-77A2-4706-971A-3DEBD522890AQ38942962-DC2639BB-CF84-42EA-AF3D-C05167026948Q39190427-16C44875-512B-4D12-9641-3D1AFD108C9EQ40549158-B4DDB0E0-20D3-48B8-89C4-4C37CBC9FE70Q40580698-41E7A7A8-74D1-4469-93EB-0FA11A16473DQ41822455-75C7E746-D662-4FFE-9857-9447B04281E9Q42088862-7972CC6D-2720-4B48-B4D9-59709E099A1CQ42747749-B079FAA2-EB14-459B-B3A8-6BF3C6AD4606Q42947312-34AF4EEB-6F47-4B1E-920D-C6108DE886CBQ43657668-73FA4A9E-BF8B-4B1F-9EC8-09BE0F20B0AA
P2860
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinases: the ...... enesis of diabetic nephropathy
@en
Matrix metalloproteinases: the ...... nesis of diabetic nephropathy.
@nl
type
label
Matrix metalloproteinases: the ...... enesis of diabetic nephropathy
@en
Matrix metalloproteinases: the ...... nesis of diabetic nephropathy.
@nl
prefLabel
Matrix metalloproteinases: the ...... enesis of diabetic nephropathy
@en
Matrix metalloproteinases: the ...... nesis of diabetic nephropathy.
@nl
P2093
P2860
P1433
P1476
Matrix metalloproteinases: the ...... enesis of diabetic nephropathy
@en
P2093
John L Fowlkes
Kathryn M Thrailkill
R Clay Bunn
P2860
P2888
P356
10.1007/S12020-008-9114-6
P577
2008-10-30T00:00:00Z